Retatrutide is a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these receptors, https://alyshauyqo078337.izrablog.com/36622015/retatrutide-a-promising-new-treatment-for-obesity